Wilson Sonsini Goodrich & Rosati
Overview
Wilson Sonsini Goodrich & Rosati is a law firm specializing in business, securities, venture capital, and intellectual property law . The firm provides a range of legal services including corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust . It represents companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as venture firms, private equity firms, and investment banks .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aeovian Pharmaceuticals | Dec 2025 | Series B | Co-investor |
| Iambic Therapeutics | Nov 2025 | VC Round | Co-investor |
| Coral Vita | Jun 2025 | Series A | Co-investor |
| BioSkryb Genomics | May 2025 | Series A | Co-investor |
| SingleFile | Feb 2025 | Series A | Co-investor |
Key People
Daniel Glazer
London Office Managing Partner
Douglas Clark
Managing Partner, Partner
Austin March
Partner
Brady Berg
Partner
Brian Keyes
Partner
Dale Bish
Partner
Damien Weiss
Partner
Dana Hall
Partner
Daniyal Iqbal
Partner
David Hoffmeister
Partner
Deirdre Carroll
Partner
Eric Tuttle
Partner
Eva F. Yin
Partner
Jad Mills
Partner
James Griffin-Stanco
Partner
Jennifer Knapp
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
